Top compounds associated with response to OGFOD1


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 4e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA TW 37 GDSC1000 pan-cancer AAC 0.14 1e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.2 4e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.14 6e-05
Download CSV